Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Binge Eating Disorders01:23

Binge Eating Disorders

538
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
538
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

975
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
975
Bulimia Nervosa01:30

Bulimia Nervosa

837
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
837
Drug Therapy01:28

Drug Therapy

316
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
316
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

555
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
555
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

800
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
800

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trauma subgroups among individuals with eating disorders: a latent profile analysis.

Journal of eating disorders·2026
Same author

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.

The International journal of eating disorders·2026
Same author

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
Same author

Finding the balance between respecting autonomy and life-saving anorexia nervosa care: an Australian perspective.

Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law·2026
Same author

Not there yet: needs and development for ngā māuiui kai (eating disorder) services in New Zealand.

The New Zealand medical journal·2026
Same author

Implementing Canadian practice guidelines for children and adolescents with eating disorders: a qualitative study on barriers, facilitating factors and implementation strategies.

Journal of eating disorders·2026

Related Experiment Video

Updated: Feb 20, 2026

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
07:46

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Published on: October 22, 2015

15.2K

Innovative Pharmacological Approaches to Eating Disorder Treatment.

Aaron Keshen1, Stephen Touyz2, Emilie Lacroix3

  • 1Department of Psychiatry, Dalhousie University, Room 3005, 5909 Veterans Memorial Lane, Halifax, Nova Scotia B3H 2E2, Canada.

The Psychiatric Clinics of North America
|February 18, 2026
PubMed
Summary
This summary is machine-generated.

Emerging pharmacologic treatments, including psychedelics and stimulants, show promise for eating disorders like anorexia nervosa and binge-eating disorder. Further clinical trials are essential to integrate these novel therapies effectively.

Keywords:
Anorexia nervosaAvoidant/restrictive food intake disorderBinge-eating disorderBulimia nervosaEating disordersPharmacotherapyPsychedelicsStimulant medications

More Related Videos

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.7K
Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

9.3K

Related Experiment Videos

Last Updated: Feb 20, 2026

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
07:46

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Published on: October 22, 2015

15.2K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.7K
Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

9.3K

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Psychology

Background:

  • Eating disorders represent complex conditions with significant biological and psychological components.
  • Current pharmacologic treatments for many eating disorders remain limited, necessitating exploration of novel therapeutic avenues.

Purpose of the Study:

  • To review innovative pharmacologic treatments for eating disorders, including psychedelics and stimulant medications.
  • To assess preliminary evidence for emerging therapies in conditions such as anorexia nervosa, binge-eating disorder, and bulimia nervosa.
  • To highlight the need for rigorous clinical trials and integration of novel treatments into existing frameworks.

Main Methods:

  • Literature review of current research on pharmacologic interventions for eating disorders.
  • Analysis of preliminary data on psychedelics (e.g., psilocybin) and stimulant medications (e.g., lisdexamfetamine).
  • Identification of research gaps for specific eating disorder diagnoses.

Main Results:

  • Preliminary evidence suggests psychedelics may enhance cognitive flexibility, aiding psychological interventions in anorexia nervosa.
  • Stimulant medications, such as lisdexamfetamine, show potential benefits for binge-eating disorder.
  • Pharmacologic treatments for avoidant/restrictive food intake disorder and bulimia nervosa are notably understudied.

Conclusions:

  • Innovative pharmacologic treatments, particularly psychedelics and stimulants, offer potential new avenues for eating disorder management.
  • Robust clinical trials are crucial to validate the efficacy and safety of these emerging therapies.
  • Integrating novel pharmacologic approaches into comprehensive treatment plans is vital for addressing the multifaceted nature of eating disorders.